Journal of the National Cancer Institute Advance Access originally published online on October 9, 2007
JNCI Journal of the National Cancer Institute 2007 99(20):1497; doi:10.1093/jnci/djm215
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
|
|
MEMO TO THE MEDIA |
PSA Velocity's Clinical Usefulness Remains Unclear
jncimedia@oxfordjournals.org
301-841-1287
| The first 10% of the full text of this article appears below. |
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool, according
Contact:
Citation:
Note to Reporters:
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 1510-1515.